Patrick Campbell

David Kingdon, MD, FRCPsych, professor of mental health care delivery at the University of Southampton, sat down with MD Magazine at APA 2019 to discuss recent advances in psychosis.

Investigators from Baylor College of Medicine found that dawn to sunset fasting may be a new treatment approach for obesity, metabolic syndrome and NAFLD.

Study from DDW 2019 found that rates of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and nonalcoholic cirrhosis was more than double in patients with UC.

A study presented at APA 2019 found that esketamine spray to be an effective, fast-acting treatment for people with treatment-resistant depression.

A study presented at DDW 2019 found that endoscopic retrieval may help prevent further gastric damage from button battery ingestion.

FDA approved midazolam nasal spray for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity distinct from a patient's usual seizure pattern in patients with epilepsy 12 years of age and older.

Study presented at DDW 2019 found that walking and resistance training was associated with a lower risk of cirrhosis-related death.

Self-reported vision impairment was associated with a greater risk of developing depression and anxiety symptoms in patients 65 and older.

A recent study found that recreational cannabis legalization can lead to increase in car accidents and injuries, but decreases in chronic pain admissions.

A recent study from the Mayo Clinic found that tramadol carries a risk of long-term use similar to that of oxycodone and hydrocodone.

Machine Learning algorithm analyzes 85 individual variables to determine a person's risk of having a heart attack or death with more than 90% accuracy.

Zebra Medical Vision received clearance for HealthPNX, an AI-based chest X-ray triage product.

Investigators found that 700 women suffer pregnancy-related deaths every year and 3 of every 5 pregnancy-related deaths were preventable.

Despite less than 2% of patients receiving surgery, they accounted for more than 25% of total expenditures within 1 year of diagnosis.

Using data from the National Health Interview Survey, investigators found major gaps in terms of receiving advice and engaging in diabetes risk-reduction activities.

A recent study found that 33.7% of patients on statins fail to lower their LDL-C to the recommended threshold of 100 mg per dL.

In a recent study, investigators from Europe found using virtual reality technology can have an impact on a patient's quality of life.

Results from the 3-year European Iluvien Registry Safety Study that examined outcomes of the fluocinolone acetonide implant compared to those of the pivotal FAME trials.

After analyzing more than 3700 systematic reviews, investigators found that 1 in 3 were unreliable.

With approval Ruzurgi becomes first treatment for LEMS approved for children.

A recent study found that black patients were far less likely to be prescribed buprenorphine than white patients.

A study presented at ARVO 2019 examines the long-term safety of BAK-free latanoprost for treatment of open-angle glaucoma or ocular hypertension

A recent study, presented at ARVO 2019, found that ophthalmologists have 77% greater odds of experiencing professional fulfillment, but ophthalmology residents are 3 times more likely to express an intent to leave the field than other surgical residents.

A study from ARVO 2019 found that, while optometrists are likely to prescribe them, many are still split over the impact of blue light-blocking devices

Pinakin Davey, DO, PhD, discusses the findings of his study comparing reliability of testing methodologies for visual acuity and contrast sensitivity at ARVO 2019.

Mia Woodward, MD, discusses the findings of her study which explored the possible over prescription and use of opioids post-corneal surgery.

Mia Woodward, MD, discusses her study examining the the inclusion of women and minorities in National Eye Institute clincal trials.

Investigators found that children who experienced concussion-related visual dysfunction had a recovery time nearly twice that of those who did not.

William Freeman, MD, of UCSD and Shiley Eye Institute, discusses the importance of creating treatments for eye diseases that make compliance easier for patients.

William Freeman, MD, discusses the results of a study he led and other potential treatments for geographic atrophy from a session he hosted at ARVO 2019.